Gene · 7068
Papers3,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,032
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacotherapeutic options for metabolic dysfunction-associated steatotic liver disease: where are we today? | Expert Opin Pharmacother | 2024 | 38954663 | PubTator, text mining | PubMed |
| Liver matrin-3 protects mice against hepatic steatosis and stress response via constitutive androstane receptor. | Mol Metab | 2024 | 38936659 | PubTator, text mining | PubMed |
| Sex-Specific Effects of THRβ Signaling on Metabolic Responses to High Fat Diet in Mice. | Endocrinology | 2024 | 38935021 | PubTator, text mining | PubMed |
| Assessment of Cardiometabolic Risk Factors and Insulin Sensitivity by Hyperinsulinemic-Euglycemic Clamp in Resistance to Thyroid Hormone β Syndrome. | Thyroid | 2024 | 38877800 | PubTator, text mining | PubMed |
| Z-number based fuzzy MCDM models for analyzing non-traditional security threats to finance supply chains: A case study from Vietnam. | Heliyon | 2024 | 38841460 | PubTator, text mining | PubMed |
| MetALD: Does it require a different therapeutic option? | Hepatology | 2024 | 38820071 | PubTator, text mining | PubMed |
| Identification of Human TRIAC Transmembrane Transporters. | Thyroid | 2024 | 38801167 | PubTator, text mining | PubMed |
| The Significance of Thyroid Hormone Receptors in Breast Cancer: A Hypothesis-Generating Narrative Review. | Curr Oncol | 2024 | 38785457 | PubTator, text mining | PubMed |
| Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease? | Metabolism | 2024 | 38782182 | PubTator, text mining | PubMed |
| Resmetirom's approval: Highlighting the need for comprehensive approaches in NASH therapeutics. | Clin Res Hepatol Gastroenterol | 2024 | 38772519 | PubTator, text mining | PubMed |
| Resmetirom: First Approval. | Drugs | 2024 | 38771485 | PubTator, text mining | PubMed |
| Resmetirom, the long-awaited first treatment for metabolic dysfunction-associated steatohepatitis and liver fibrosis? | Med | 2024 | 38733968 | PubTator, text mining | PubMed |
| Obesity disrupts the pituitary-hepatic UPR communication leading to NAFLD progression. | Cell Metab | 2024 | 38718793 | PubTator, text mining | PubMed |
| THRB Gene Mosaicism Confirmed by Next-Generation Sequencing in a Clinically Symptomatic Infant. | JCEM Case Rep | 2024 | 38707653 | PubTator, text mining | PubMed |
| Effects of N-acetylcysteine on the expressions of UCP1 and factors related to thyroid function in visceral adipose tissue of obese adults: a randomized, double-blind clinical trial. | Genes Nutr | 2024 | 38702594 | PubTator, text mining | PubMed |
| Role of Resmetirom, a Liver-Directed, Thyroid Hormone Receptor Beta-Selective Agonist, in Managing Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis. | Endocr Pract | 2024 | 38697306 | PubTator, text mining | PubMed |
| Editorial: The role of thyroid hormones in vertebrate development, volume II. | Front Endocrinol (Lausanne) | 2024 | 38694947 | PubTator, text mining | PubMed |
| Selective Agonists of Thyroid Hormone Receptor Beta: Promising Tools for the Treatment of Nonalcoholic Fatty Liver Disease. | Endocrinol Metab (Seoul) | 2024 | 38693819 | PubTator, text mining | PubMed |
| Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease. | Med Rev (2021) | 2024 | 38680683 | PubTator, text mining | PubMed |
| Metabolic Messengers: Thyroid Hormones. | Nat Metab | 2024 | 38671149 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7068/papers?page=15